期刊
CURRENT HYPERTENSION REPORTS
卷 13, 期 4, 页码 269-275出版社
SPRINGER
DOI: 10.1007/s11906-011-0204-0
关键词
Preeclampsia; Placental ischemia; Placental hypoxia; VEGF; sFlt-1; Heme oxygenase-1; Endothelin-1; Sildenafil; Hypertension; Pregnancy; Treatment
资金
- NHLBI NIH HHS [R01 HL108618] Funding Source: Medline
Preeclampsia is a pregnancy-induced hypertensive disorder found most commonly in nulliparous women. Recent research performed in animal models of the disease has revealed some of the underlying mechanisms of preeclampsia. Specifically, placental insufficiency and the resulting hypoxia/ischemia have been shown to be crucial to disease progression. In response to placental hypoxia/ischemia, several pathways are activated, which contribute to the clinical manifestations of the disease: increased circulating levels of the anti-angiogenic protein sFlt-1, activation of the maternal inflammatory response, suppressed nitric oxide production, enhanced endothelin-1 production, and induction of reactive oxygen formation. Despite advances in the understanding of the disorder, therapeutic approaches to the treatment of preeclampsia are severely limited. New lines of research, however, indicate some possible new therapeutic approaches for the management of preeclampsia and offer hope for an effective pharmacologic intervention.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据